Monitoring Bone Density with Repeat DEXA Scans:what to expect

Every DEXA machine has a small amount of measurement variability — the same patient scanned twice on the same day will get slightly different numbers. The Least Significant Change is the smallest difference between two scans that is bigger than this noise and therefore likely to be real.

• LSC is usually expressed as a percentage and is typically around 3 to 5 percent for the spine and hip on modern DEXA machines.
• An LSC value should be calculated for each individual scanner — it depends on the machine, the radiographer, and the center's quality control.
• A change in your BMD that is smaller than the LSC is considered "no significant change."
• A change larger than the LSC in the same direction is considered real.

If your second scan's BMD is 1.5% different from your first scan but the center's LSC is 4%, your bones have not measurably changed. This is normal and not bad news.

Doctors usually monitor changes in raw bone mineral density (g/cm²), not the T-score, because:

• T-scores are based on reference databases that vary slightly between machines.
• Small changes in raw BMD can produce confusing-looking T-score changes that are not actually meaningful.

You may see the T-score change between scans, but the doctor's interpretation is usually anchored on the BMD trend at each site.

A real (above-LSC) decline in BMD without a fracture is still important information. It usually triggers a discussion about whether to escalate treatment, look for a secondary cause, or address adherence. It is rare for someone to have meaningful bone loss while taking osteoporosis medication correctly.

Some centers now include a vertebral fracture assessment (VFA) — a low-dose DEXA image of the spine — at follow-up scans. This is useful because vertebral fractures often occur silently and may change the treatment plan even when the BMD looks stable.

DXA measures two-dimensional areal bone mineral density; it does not measure every aspect of bone strength. Arthritis, vertebral compression, calcification, previous surgery, metalwork, positioning, and differences between machines can distort results. Fracture risk must combine the usable DXA sites with age, previous fractures, medicines, falls, medical conditions, and—when appropriate—a validated risk tool.

A fragility fracture can justify an osteoporosis diagnosis or treatment assessment even when the T-score is not in the osteoporosis range. For monitoring, compare valid studies from the same facility and machine where possible, and only call a change real when it exceeds that facility's least significant change (LSC). The timing of another scan should be individualised.

Repeat DEXA scans are done to:

• Confirm a diagnosis — sometimes a borderline result is rechecked after 1 to 2 years to be sure.
• Monitor untreated low bone density — to see whether bone loss is progressing or stable.
• Assess response to treatment — to confirm that an osteoporosis medication is working.
• Restart the conversation — after stopping a medication, after menopause, or after starting a drug that affects bone.

If you have to switch centers, the new center may need to do a "cross-calibration" or simply treat the new scan as a fresh baseline.

For most osteoporosis medications:

• A stable or improving BMD after 1 to 2 years is considered a good response. "No change" on treatment is often the goal — it means bone loss has been halted.
• A drop in BMD that exceeds the LSC suggests the treatment is not working, the patient is not taking it consistently, or there is a secondary cause that has not been addressed.

Spine BMD often responds first and largest to treatment, because of its higher trabecular content. Hip BMD changes more slowly. Both sites are worth tracking.

Yes, but it is uncommon if the treatment is being taken correctly. The most common reasons for an apparent "worsening" while on treatment are:

• Not taking the medication consistently — particularly oral bisphosphonates, which require specific dosing on an empty stomach.
• Vitamin D deficiency — treatment works much less well when vitamin D levels are low.
• An undiagnosed secondary cause — such as hyperparathyroidism, malabsorption, or excessive thyroid replacement.
• Measurement variability below the LSC that is misread as "worsening."

A genuine drop in BMD on treatment is worth investigating, not just shrugging off.

This is one of the most common patient questions, and the honest answer is: it depends on why the first scan was done. Typical intervals:

There is no universal schedule. Timing depends on the baseline BMD, age, fracture risk, medication and expected rate of change, new fracture or risk factor, and whether the result will alter treatment. A repeat should be late enough for an expected biological change to exceed the facility's LSC; in selected situations with rapid bone loss, an earlier study may be justified.

• International Society for Clinical Densitometry: 2023 Adult Official Positions
• RadiologyInfo.org: Bone density scan (DXA)

A repeat DEXA is most valuable when there is a specific question to answer — confirming treatment response, checking on progressive bone loss, or revisiting a borderline result. The change between scans should be measured against the center's least significant change before drawing conclusions. Use the same imaging center when you can, bring your previous report, and read the trend over years rather than reacting to a single number.